[Proteasome inhibition as a new strategy in cancer therapy and chemoprevention]

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• The ubiquitin-proteasome system (UPS) is crucial for cellular homeostasis, degrading proteins involved in key processes.
• UPS dysfunction is implicated in various diseases, including cancer.
• Proteasomal degradation targets proteins regulating signal transduction, metabolism, cell cycle, and apoptosis.

Purpose of the Study:

• To review known proteasome inhibitors.
• To emphasize their effects on apoptosis and cell cycle control.
• To highlight the potential of UPS inhibition as a cancer therapy.

Main Methods:

• Literature review of proteasome inhibitors.
• Analysis of their chemical structures and mechanisms of action.
• Summary of reported effects on intracellular phenomena.

Main Results:

• Proteasome inhibitors exhibit diverse chemical structures and mechanisms.
• Inhibition of the UPS leads to cell proliferation arrest.
• UPS inhibition effectively induces apoptosis, particularly in cancer cells.

Conclusions:

• The ubiquitin-proteasome system is a validated target for cancer therapy.
• Proteasome inhibitors demonstrate significant anti-cancer effects by disrupting cell cycle and inducing apoptosis.
• Clinical trials support the therapeutic potential of targeting the UPS in oncology.